The Effects of Covid 19 on Psychiatric Disorders

The COVID-19 pandemic has profoundly impacted global mental health, exacerbating pre-existing psychiatric conditions and triggering new-onset mental health disorders. This CME/CE course explores how the pandemic has contributed to atypical presentations of psychiatric conditions and provides strategies to diagnose, manage, and treat these unique manifestations.

Participants will gain a deep understanding of how SARS-CoV-2 infection, prolonged isolation, grief, economic instability, and healthcare disruptions have influenced the clinical landscape of psychiatric care. The course outlines shifts in symptomatology and presentation, including atypical depression, health anxiety, COVID-induced psychosis, and trauma-related disorders emerging in the wake of prolonged ICU stays or pandemic-related loss.

Special attention is given to the neuropsychiatric effects of long COVID, where patients may experience persistent cognitive impairments, emotional lability, and affective dysregulation. Case studies will help learners identify atypical mood disorders and psychotic features influenced by viral neurotropism, immune dysregulation, and psychosocial stressors.

Treatment modalities are examined from a pandemic-sensitive lens, covering telepsychiatry best practices, community-based interventions, psychopharmacological considerations, and trauma-informed care. The course also explores digital mental health tools, peer support networks, and the integration of public health principles in mental health planning.

By course completion, healthcare professionals will be equipped to adapt their clinical practice to recognize COVID-19-related deviations in psychiatric symptomatology, apply up-to-date treatment approaches, and promote long-term recovery for affected individuals in diverse healthcare settings.

Educational Objectives

• Describe the atypical presentation of psychiatric disorders influenced by COVID-19 and its aftermath.
• Identify strategies to manage and differentiate atypical psychiatric symptoms from standard diagnostic presentations.
• List the latest pharmacological, psychotherapeutic, and digital treatment modalities for psychiatric disorders shaped by the COVID-19 pandemic.

Who Should Do This Course?

This course is designed for:

• Psychiatrists, psychologists, and behavioral health providers adapting care for post-COVID psychiatric challenges.
• Internists, family physicians, and primary care providers encountering mental health presentations in post-COVID patients.
• Public health officials and infectious disease specialists addressing the psychiatric sequelae of COVID-19 at the community level.
• Geriatricians and long-term care clinicians managing cognitive and affective symptoms of post-viral psychiatric illness.
• Nurse Practitioners and Physician Assistants delivering integrated mental and physical healthcare across clinical settings.

Did You Know?

• One in three COVID-19 survivors are diagnosed with a neurological or psychiatric disorder within six months. (The Lancet Psychiatry, 2021)
• Rates of new-onset depression and anxiety increased by more than 25% globally during the first year of the pandemic. (WHO, 2022)
• Telehealth usage for behavioral health increased 38-fold between 2019 and 2021. (McKinsey & Company, 2021)
• Up to 80% of long COVID patients report neuropsychiatric symptoms such as fatigue, depression, or brain fog. (Nature Reviews Neurology, 2022)
• COVID-19-related PTSD is prevalent even among non-hospitalized individuals, particularly healthcare workers. (JAMA Network Open, 2022)